Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Age- and tissue-specific induction of NHE3 by glucocorticoids in the rat small intestine.

American journal of physiology. Cell physiology·2001

Same author

A single residue contributes to the difference between Kir4.1 and Kir1.1 channels in pH sensitivity, rectification and single channel conductance.

The Journal of physiology·2000

Same author

Molecular determinants for the distinct pH sensitivity of Kir1.1 and Kir4.1 channels.

American journal of physiology. Cell physiology·2000

Same author

Interaction of different oligomeric states of hexameric DNA-helicase RepA with single-stranded DNA studied by analytical ultracentrifugation.

FEBS letters·2000

Same author

Function of GATA transcription factors in preadipocyte-adipocyte transition.

Science (New York, N.Y.)·2000

Same author

DNA helicase RepA: cooperative ATPase activity and binding of nucleotides.

Biochemistry·2000

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair

Published on: February 24, 2016

Composite tissue transplantation: a rapidly advancing field.

K V Ravindra¹, S Wu, L Bozulic

¹Department of Surgery, University of Louisville, Louisville, Kentucky, USA.

Transplantation Proceedings

|July 1, 2008

Summary

Composite tissue allotransplantation (CTA) offers solutions for complex defects but requires lifelong immunosuppression. Mixed chimerism via bone marrow transplantation shows promise for promoting tolerance and reducing immunosuppression needs in CTA.

More Related Videos

Experimental Approaches to Tissue Engineering

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model

Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model

Published on: April 1, 2019

Related Experiment Videos

Last Updated: Jul 4, 2026

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair

Published on: February 24, 2016

Experimental Approaches to Tissue Engineering

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model

Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model

Published on: April 1, 2019

Area of Science:

Regenerative Medicine
Transplantation Immunology

Background:

Composite tissue allotransplantation (CTA) is an emerging treatment for complex tissue defects, with increasing clinical feasibility demonstrated in hand, facial, and other allografts.
Lifelong immunosuppression is a major limitation of CTA due to toxicity, hindering widespread application.

Purpose of the Study:

To review the current landscape of CTA, focusing on immunology, preclinical models, clinical experience, and tolerance induction strategies.
To explore the potential of mixed chimerism through bone marrow transplantation to overcome immunosuppression requirements in CTA.

Main Methods:

Literature review of CTA history, applications, and immunology.
Analysis of preclinical animal models and clinical experiences with CTA.
Examination of advances and challenges in mixed chimerism-induced tolerance for CTA.

Main Results:

CTA has demonstrated feasibility in various complex reconstructions.
Mixed chimerism is a promising strategy for promoting allograft acceptance and reducing immunosuppression.
Hurdles remain in applying bone marrow chimerism effectively for CTA tolerance.

Conclusions:

Reducing or eliminating immunosuppression is critical for advancing CTA.
Mixed chimerism presents a significant frontier for inducing tolerance in CTA.
Further research is needed to overcome challenges in bone marrow chimerism-based tolerance induction for CTA.